ANDREA CURTIS: Open Payments
NPI 1699340802 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 30 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $44 · 2025 $677
Food & beverage: $578Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $206 |
| Orexo US, Inc. | 3 | $72 |
| Genentech USA, Inc. | 3 | $66 |
| Alkermes, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Genmab U.S., Inc. | 1 | $24 |
| Braeburn Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Boston Scientific Corporation | 1 | $21 |
Products named: DARZALEX, Zubsolv, VIVITROL, Epkinly, Polivy, ERLEADA, KISQALI, BRIXADI.
Industry payments across MI — which companies pay providers there.
